News

WTAP24m
FDA Warns Dangers of Drug “7-OH”
HHS Sec. Robert F. Kennedy, Jr. and Sen. Markwayne Mullin (R-OK), along with FDA Commissioner Dr. Marty Makary, announce new ...
Just The News38m
FDA allows distribution of muscular dystrophy drug again after public criticism
The agency’s now-reversed decision to halt distribution of a gene therapy for children suffering from muscular dystrophy ...
FDA calls for kratom restrictions
A popular but controversial supplement is back in the national spotlight. The FDA announced new moves to restrict a powerful compound found in some kratom products, saying it's as strong as morphine ...
STAT1h
Vinay Prasad, a powerful FDA official, departs after controversy over rare disease drug
Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial ...
BioSpace1h
Prasad Out at CBER Following Sarepta Rollercoaster and Conservative Criticism
The FDA’s dramatic summer continues to unfold as news broke late Tuesday evening that Vinay Prasad will depart the agency, ...
US FDA's chief medical and science officer Prasad departs agency
Vinay Prasad, the U.S. Food and Drug Administration's chief medical and science officer, has left the health regulator, the U ...
Atlanta News First2h
FDA recommends classifying kratom byproduct as controlled substance
Pope was pleased to hear that the Food and Drug Administration (FDA) recommended a scheduling action for the active ...
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain
Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion as the Company prepares to launch U.S. Phase 2a by year-end MIAMI, FLORIDA / ...
US health officials crack down on kratom-related products after complaints from supplement industry
In recent months, dietary supplement companies that sell kratom have been urging the Food and Drug Administration to crack ...
US FDA's Vinay Prasad leaves health regulator, STAT News reports
Vinay Prasad, the U.S. Food and Drug Administration's chief medical and science officer, has left the health regulator, STAT ...
Controversial FDA official Dr. Vinay Prasad departs agency
Dr. Vinay Prasad, the controversial critic of the US Food and Drug Administration who took a top role at the regulatory ...
FDA asks DOJ to classify gas station products with opioid-like effects as illicit substances
The Food and Drug Administration on Tuesday recommended classifying 7-OH, a compound with opioid-like effects found in ...